(Q39002175)

8 September 2017

Cytokines: The Good, the Bad, and the Deadly (English)

1 reference

8 September 2017

Thulasi Ramani

1

1 reference

8 September 2017

Carol S Auletta

2

1 reference

8 September 2017

Daniel Weinstock

3

1 reference

8 September 2017

Barbara Mounho-Zamora

4

1 reference

8 September 2017

Patricia C Ryan

5

1 reference

8 September 2017

Theodora W Salcedo

6

1 reference

8 September 2017

Gregory Bannish

7

1 reference

8 September 2017

26 May 2015

1 reference

International Journal of Toxicology

8 September 2017

1 reference

8 September 2017

34

1 reference

8 September 2017

4

1 reference

8 September 2017

355-365

1 reference

Cytokines and anti-cytokines as therapeutics--an update.

8 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Comparison of novel methods for predicting the risk of pro-inflammatory clinical infusion reactions during monoclonal antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

In vitro cytokine release assays for predicting cytokine release syndrome: the current state-of-the-science. Report of a European Medicines Agency Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Cytokine release assays: current practices and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Managing cytokine release syndrome associated with novel T cell-engaging therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Current concepts in the diagnosis and management of cytokine release syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Development and homeostasis of T cell memory in rhesus macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

CD28-specific immunomodulating antibodies: what can be learned from experimental models?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Fit-for-purpose method development and validation for successful biomarker measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Origin and physiological roles of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

EN-RAGE: a novel inflammatory marker for incident coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Longitudinal Cytokine Expression during IMRT for Prostate Cancer and Acute Treatment Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

Evaluation of FR104, a Treg sparing antagonist anti-CD28 monovalent Fab’ antibody in kidney transplantation in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581815584918

21 January 2018

Identifiers

DOI

10.1177/1091581815584918

1 reference

8 September 2017

1 reference